Study Finds Surprising Link Between Aspirin in Seniors and Cancer Mortality

Study Finds Surprising Link Between Aspirin in Seniors and Cancer Mortality

(MedPage Today) -- Low-dose aspirin was not associated with a reduced incidence of cancer in older adults, but was associated with an increased risk of dying of cancer, according to a cohort study of participants from the randomized ASPREE trial...

Taking daily aspirin does not reduce long-term cancer risk for older adults

Prior studies, largely among middle-aged adults, have reported that taking aspirin reduces the risk of cancer after 10 years, particularly for colorectal cancer. However, new Monash University research has found that for healthy older adults who took a low-dose of aspirin daily, there was no effect on overall cancer incidence but increased risk of cancer-related mortality.

Daily aspirin use linked to higher cancer death risk in older adults, major study finds

New Monash University study finds daily low-dose aspirin increases cancer mortality risk by 15 per cent in older adults, debunking previous prevention myths.

Taking daily aspirin does not reduce long-term cancer risk for older a